Searched for
ASTRAZENECA LYNPARZA
AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drugAstraZeneca Pharma India has voluntarily surrendered the marketing authorisation for its prostate cancer drug Olaparib (Lynparza) 100mg and...15 Apr, 2025, 01.48 PM IST- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...20 Feb, 2025, 06.11 PM IST
- MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...03 Dec, 2024, 04.06 PM IST
- AstraZeneca Pharma gets CSDCO nod to import anti-cancer drug LynparzaAstraZeneca Pharma India has received regulatory approval to import and distribute Lynparza (Olaparib) tablets in 100mg and 150mg doses. Th...26 Nov, 2024, 03.00 PM IST
- Be bullish, just manage risks & desire; 5 midcap stocks for long term investorsIn a bullish market many things change and one of them is the relationship between opportunity and challenges. Given the way markets are pa...14 Jul, 2024, 03.53 PM IST
- Indian companies have made a comeback. Will MNCs be able to do it ? 7 MNC pharma stocks with upside potential of up to 21%While they still trade at premium valuations, they have not created wealth for shareholders. The fact is an age-old theory that just having...24 Jun, 2024, 04.53 PM IST
- AstraZeneca bets on licencing deals, public-private partnerships for India growthBritish-Swedish drugmaker AstraZeneca is set to launch 15 new products in India from 2023 to 2025, focusing on oncology, cardiovascular, re...09 Mar, 2024, 12.53 AM IST
- Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of thes...23 Feb, 2024, 03.29 PM IST
- For calibrating and diversifying risks? 6 midcap stocks from different sectors with the right financial matrixAs the Dalal street continues to be in party mode, staying bullish would appear to be the most logical thing at this point of time. Why fig...13 Jan, 2024, 02.37 PM IST
- Natco Pharma submits application with USFDA for generic cancer drugThe company has submitted an Abbreviated New Drug Application (ANDA) containing a 'paragraph IV' certification with the US Food and Drug Ad...13 Feb, 2023, 02.56 PM IST
- Stocks in the news: LIC, JSW Steel, L&T, Adani Power, Paytm and pharma stocksInsurance behemoth LIC witnessed a decline of nearly 20 per cent in death claims in the first quarter of this fiscal with the COVID impact ...22 Aug, 2022, 07.32 AM IST
- AstraZeneca India receives DCGI's nod to market drug treating breast cancerThe Drugs Controller General of India (DCGI) has approved Lynparza (Olaparib) as a monotherapy for the treatment of adult patients with ear...19 Aug, 2022, 05.48 PM IST
- FTSE 100 slips as growth worries persistThe blue-chip FTSE 100 index eased 0.3%. Retail stocks, industrial miners and life insurers were the top losing sectors.24 Sep, 2021, 01.52 PM IST
- Covid-19 vaccine deliveries on ice as AstraZeneca awaits trial dataAstraZeneca said on Thursday it was holding back deliveries while it awaits the data from late-stage clinical trials in order to maximise t...05 Nov, 2020, 05.40 PM IST
Load More
